Eyad ALMOUAZEN is an accomplished professional in the field of pharmaceutical sciences and formulation development. Currently serving as a Formulation Senior Scientist in R&D Bio at Virbac since September 2021, Eyad leads the development of vaccines and biological drug products, overseeing formulation strategies, analytical processes, and packaging. Eyad has extensive experience in academia, having taught formulation science at CPE Lyon since 2010 and previously held positions as an Assistant Professor and Research Scientist at ISPB-Faculté de Pharmacie, Université Claude Bernard Lyon 1 from 2014 to 2021. Eyad's research focus includes innovative drug and vaccine delivery systems, as well as the development of polymeric nanoparticles. Eyad's educational background includes a Doctorate in Pharmaceutical Sciences from Université Claude Bernard Lyon 1, along with master's degrees in Biomedical and Pharmaceutical Engineering and Cosmetic Formulation.
Upgrade to view 0 reports
This person is not in any offices
Virbac
1 followers
Virbac provides innovative solutions to veterinarians, farmers, and animal owners in more than 100 countries around the world. Covering more than 50 species, their range of products and services enables them to diagnose, prevent and treat the majority of pathologies.
Ad